Cancer testing technology that could 'transform' process handed millions
A SCOTTISH medical technology company has announced £2.1 million additional seed financing – in an oversubscribed funding round – to complete…
Stay updated with breaking news from Tim Aitman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A SCOTTISH medical technology company has announced £2.1 million additional seed financing – in an oversubscribed funding round – to complete…
/PRNewswire/ -- BIOCAPTIVA Ltd ("BIOCAPTIVA"), a company developing the BioCaptis – a revolutionary cell-free DNA (cfDNA) capture device designed to transform...
The funds will help the company complete its first study of the cell-free DNA capture device in humans and to plan future regulatory trials.
A University of Edinburgh spin-out that says it is pioneering technology to “transform” liquid biopsy testing in cancer-management has announced an oversubscribed £2.1 million additional seed funding round led by Archangels.
Deal financing led by existing investor, Archangels, with participation from Scottish Enterprise, Cancer Research Horizons and new investor Old College Capital, the University of Edinburgh's